Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase

Gene Therapy

Volumn 3, Issue 5, 1996, Pages 381-388

  Askari, F K ^a,c   Hitomi, Y ^a   Mao, M ^a   Wilson, J M ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bile; Bilirubin; Gene therapy; Hepatocyte; Vector

Indexed keywords

BILIRUBIN; COMPLEMENTARY DNA; DNA; GLUCURONOSYLTRANSFERASE; PROTEIN; RNA; SULFUR 35;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRIGLER NAJJAR SYNDROME; DNA DETERMINATION; ENHANCER REGION; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; HYPERBILIRUBINEMIA; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; ISOTOPE LABELING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; RAT; RECOMBINANT GENE; RNA ANALYSIS; SOUTHERN BLOTTING; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BILIRUBIN; CRIGLER-NAJJAR SYNDROME; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLUCURONOSYLTRANSFERASE; HUMANS; HYPERBILIRUBINEMIA; IN SITU HYBRIDIZATION; RATS; RATS, GUNN;

EID: 0029943497     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jaffe HA et al Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet 1992; 1: 372-378.
2. Qiuntang L et al. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993; 4: 403-409.
3. Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors. Curr Opin Gen Dev 1993; 3: 499-503.
4. Engelhardt JF, Xuehai Y, Doranz F, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994; 91: 6196-6200.
5. Kozarsky K, Grossman M, Wilson JM. Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Som Cell Mol Gen 1993; 19: 449-458.
6. Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 1994; 7: 362-369.
7. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
8. Kozarsky KF et al. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994; 269: 13695-13702.
9. Crigler JF, Najjar VA. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 1952; 10: 169-170.
10. Brierley CH, Burchell B. Human UDP-glucuronosyltransferases: chemical defence, jaundice and gene therapy. BioEssays 1993; 15: 749-754.
11. Askari FK, Hitomi E, Thiney M, Wilson JM. Retrovirus mediated expression of the HUG Br1 in Crigler-Najjar syndrome type I human fibroblasts and correction of the genetic defect in Gunn rat hepatocytes. Gene Therapy 1995; 2: 203-208.
12. Fox IJ et al. Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer. Hepatology 1995; 21: 837-846.
13. Askari FK et al. Construction of retroviral vectors for transferring human bilirubin UDP-glucuronosyltransferase: toward gene therapy for Crigler-Najjar syndrome type I. Hepatology 1991; 14: (abstr. 126a).
14. Iyanagi T. Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat). J Biol Chem 1991; 266: 24048-24052.
15. Ritter JK, Crawford JM, Owens IS. Cloning of two human liver bilirubin UDP-glucuronosyltransferse cDNAs with expression in COS-1 cells. J Biol Chem 1991; 266: 1043-1047.
16. Aono S et al. A new type of defect in the gene for bilirubin uridine 5′-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I. Pediatr Res 1994; 35: 629-632.
17. Bosma PJ et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994; 269: 17960-17964.
18. Engelhardt JF, Litzky L, Wilson JM. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther 1994; 5: 1217-1229.
19. Boshart M et al. A very strong enhancer is located upstream of an immediate-early gene of human cytomegalovirus. Cell 1985; 41: 521-530.
20. Askari FK, Hitomi E, Hitomi Y, Wilson JM. Construction of adenoviral vectors expressing human bilirubin UDP-glucuronosyltransferases for the complementation of Crigler-Najjar syndrome type I. Hepatology 1994; 20: (Abstr. 321a).
21. Yamashita M, Adachi Y, Yamamoto T. Analysis of bilirubin conjugates in human bile by column liquid chromatography. J Chromatogr 1986; 375: 386-391
22. Wilson JM et al. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc Natl Acad Sci USA 1990; 87: 8437-8441.
23. Higgs JB et al. A novel pathway of human T lymphocyte activation. Identification by a monoclonal antibody generated against a rheumatoid synovial T cell line. J Immunol 1988; 140: 3758-3765.
24. Blanckaert N. Analysis of bilirubin and bilirubin mono- and di-conjugates. Determination of their relative amounts in biological samples. Biochem J 1980; 185: 115-128.